Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cell Cycle Analysis of the Cd133+ and Cd133- Cells Isolated From Human Colorectal Cancer Publisher Pubmed



Gharagozloo M1 ; Mirzaei HR1 ; Bagherpour B1 ; Rezaei A1 ; Kalantari H2 ; Sanei MH3 ; Hosseini M4 ; Mohajeri G5 ; Tabatabai A5 ; Hashemi M5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Gasteroentrology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Biostatistics and Epidemiology, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. Department of Surgery, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Cancer Research and Therapeutics Published:2012


Abstract

Aim: The CD133 antigen has been identified as a putative stem cell marker in colorectal cancer tissues. The aim of this study was to investigate the cell cycle state of CD133+ and CD133- cells, isolated from primary human colorectal tumors. Materials and Methods: After mechanical and enzymatic dissociation of the tumor samples, CD133+ and CD133 - subsets were identified and separated by magnetic cell sorting. Flow cytometric analysis was performed to compare the cell cycle of both CD133+ and CD133- cells isolated from primary and liver metastatic cancer cells. Results: The results indicated that CD133+ cells isolated from both primary and liver metastatic colorectal cancers were found in higher percentage in the G0/G1 phases. However, the CD133- cells isolated from primary colorectal cancers were predominantly found in the S and G2/M phases. Surprisingly, the CD133- cells isolated from liver metastatic colorectal cancers were mostly found in the G0/G1 phase. Conclusion: The present study provides evidence that CD133+ cells are in a quiescent state in colorectal cancer, representing a mechanism that would at least partially explain chemotherapy resistance and tumor recurrence in post-Therapy patients.